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Background
CD4 cell depletion is central to HIV pathogenesis. How-
ever, CD4 cells present diverse lineages and the relative
impact of HIV on Th17 and regulatory T cell (Treg) subsets
remains unclear. CD161+ CD4 cells are a recently identi-
fied, gut-homing population with Th17 precursor poten-
tial. The balance between pro-inflammatory Th17 cells
and immunoregulatory Tregs may be critical in HIV
pathogenesis. This study addressed changes in CD161+,
Th17 and Treg subsets during untreated HIV infection.
Methods
Peripheral blood mononuclear cells (PBMC) were iso-
lated from 77 untreated HIV-infected and 36 HIV-unin-
fected subjects and stained with fluorochrome-conjugated
monoclonal antibodies to characterize CD161+ CD4
cells; Th17 cells (expression of CCR6 and elaboration of
IL-17A after PMA/ionomycin stimulation); Tregs
(CD4+CD25hiFoxP3+ cells); and CD8 activation
(CD38+/HLA-DR+ cells). In vitro infectability of CD161+
and Th17 cells was assessed by incubating activated
healthy donor CD4 cells with HIV Bal for 5 days and co-
staining for CD161/IL-17A and intracellular p24.
Results
Peripheral blood Th17 cells were depleted 10-fold in HIV-
infected, compared to HIV-uninfected, subjects (P <
0.0001) across a range of disease stages, accompanied by
a significant reduction of CD161+ T cells (P = 0.024).
Both Th17 cells and CD161+ CD4 cells were highly tar-
geted by HIV in vitro. The preferential and early loss of
Th17 cells contrasted with a gradual decline in absolute
Treg numbers during HIV disease progression in untreated
subjects followed longitudinally (R = 0.71, P = 0.003).
Loss of Tregs was associated with increased immune acti-
vation (R = -0.33, P = 0.03).
Conclusion
HIV-infected subjects showed preferential loss of Th17
and CD161+ CD4 subsets, which were both highly tar-
geted by HIV in vitro. Loss of CD161+ cells, which are
Th17 cell precursors, may limit Th17 reconstitution. A
gradual decline in Tregs during disease progression was
associated with increased immune activation. Loss of
both Th17 and Treg subsets may enhance disease progres-
sion through impaired mucosal defences, and increase in
immune activation.
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